GlassScriptPhysician profile
Laura G Ford
NPI 1407286784
$1,370.90
in general payments reported to CMS, 2019-2025
16 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $174 · 2023: $325 · 2024: $383 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $305.91 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $250.38 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $144.28 | 2021-2025 | |
| Abbvie INC. | $139.12 | 2022-2025 | |
| Novo Nordisk INC | $89.63 | 2021-2025 | Wegovy |
| Amgen INC. | $75.12 | 2021-2025 | Evenity, Prolia, Repatha |
| Dexcom, INC. | $70.41 | 2021-2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $69.38 | 2021-2025 | Trelegy Ellipta |
| Philips North America LLC | $63.54 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck7) Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.38 | 2021-2023 | Jardiance |
| Exact Sciences Corporation | $33.67 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $24.56 | 2023 | |
| Phathom Pharmaceuticals, INC. | $20.57 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.34 | 2024 | Caplyta |
| Eagle Pharmaceuticals, INC. | $13.73 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $3.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.